Deciphera Pharmaceuticals Inc’s latest rating changes from various analysts

In a filing, Deciphera Pharmaceuticals Inc revealed its Chief Financial Officer Kelly Thomas Patrick unloaded Company’s shares for reported $47009.0 on Feb 16 ’24. In the deal valued at $15.62 per share,3,010 shares were sold. As a result of this transaction, Kelly Thomas Patrick now holds 80,350 shares worth roughly $1.19 million. Then, Sherman Matthew […]

Deciphera Pharmaceuticals Inc (DCPH) Becoming More Attractive for Investors

In a filing, Deciphera Pharmaceuticals Inc revealed its Chief Financial Officer Kelly Thomas Patrick unloaded Company’s shares for reported $47009.0 on Feb 16 ’24. In the deal valued at $15.62 per share,3,010 shares were sold. As a result of this transaction, Kelly Thomas Patrick now holds 80,350 shares worth roughly $1.2 million. Then, Sherman Matthew […]

Deciphera Pharmaceuticals Inc (DCPH) receives a Neutral rating from JP Morgan

Deciphera Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Kelly Thomas Patrick unloaded Company’s shares for reported $47009.0 on Feb 16 ’24. In the deal valued at $15.62 per share,3,010 shares were sold. As a result of this transaction, Kelly Thomas Patrick now holds 80,350 shares worth roughly $1.29 million. Then, Sherman Matthew L […]

Deciphera Pharmaceuticals Inc [DCPH] Insider Selling: Time to sell?

Deciphera Pharmaceuticals Inc’s recent filing unveils that its Chief Financial Officer Kelly Thomas Patrick unloaded Company’s shares for reported $47009.0 on Feb 16. In the deal valued at $15.62 per share,3,010 shares were sold. As a result of this transaction, Kelly Thomas Patrick now holds 80,350 shares worth roughly $1.36 million. Then, Sherman Matthew L […]